title: Expression of human alpha 2-adrenergic receptors in adipose tissue of beta 3-adrenergic receptor-deficient mice promotes diet-induced obesity.
abstract: Catecholamines play an important role in controlling white adipose tissue function and development. beta- and alpha 2-adrenergic receptors (ARs) couple positively and negatively, respectively, to adenylyl cyclase and are co-expressed in human adipocytes. Previous studies have demonstrated increased adipocyte alpha 2/beta-AR balance in obesity, and it has been proposed that increased alpha 2-ARs in adipose tissue with or without decreased beta-ARs may contribute mechanistically to the development of increased fat mass. To critically test this hypothesis, adipocyte alpha 2/beta-AR balance was genetically manipulated in mice. Human alpha 2A-ARs were transgenically expressed in the adipose tissue of mice that were either homozygous (-/-) or heterozygous (+/-) for a disrupted beta 3-AR allele. Mice expressing alpha 2-ARs in fat, in the absence of beta 3-ARs (beta 3-AR -/- background), developed high fat diet-induced obesity. Strikingly, this effect was due entirely to adipocyte hyperplasia and required the presence of alpha2-ARs, the absence of beta 3-ARs, and a high fat diet. Of note, obese alpha 2-transgenic beta 3 -/- mice failed to develop insulin resistance, which may reflect the fact that expanded fat mass was due to adipocyte hyperplasia and not adipocyte hypertrophy. In summary, we have demonstrated that increased alpha 2/beta-AR balance in adipocytes promotes obesity by stimulating adipocyte hyperplasia. This study also demonstrates one way in which two genes (alpha 2 and beta 3-AR) and diet interact to influence fat mass.
authors.affiliation: Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA.
authors.forename: P
authors.initials: P
authors.lastname: Valet
authors.forename: D
authors.initials: D
authors.lastname: Grujic
authors.forename: J
authors.initials: J
authors.lastname: Wade
authors.forename: M
authors.initials: M
authors.lastname: Ito
authors.forename: M C
authors.initials: MC
authors.lastname: Zingaretti
authors.forename: V
authors.initials: V
authors.lastname: Soloveva
authors.forename: S R
authors.initials: SR
authors.lastname: Ross
authors.forename: R A
authors.initials: RA
authors.lastname: Graves
authors.forename: S
authors.initials: S
authors.lastname: Cinti
authors.forename: M
authors.initials: M
authors.lastname: Lafontan
authors.forename: B B
authors.initials: BB
authors.lastname: Lowell
mesh_terms: D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D004041:Dietary Fats / Q000008:administration & dosage*; D004837:Epinephrine / Q000378:metabolism; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D009765:Obesity / Q000235:genetics*; D018341:Receptors, Adrenergic, alpha-2 / Q000235:genetics / Q000378:metabolism*; D022702:Receptors, Adrenergic, beta-3 / Q000235:genetics / Q000502:physiology*
chemical_list: D004041:Dietary Fats; D018341:Receptors, Adrenergic, alpha-2; D022702:Receptors, Adrenergic, beta-3; D004837:Epinephrine